National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-9305, USA.
Université Libre de Bruxelles 1070 Brussels, Belgium.
Sci Transl Med. 2015 Jun 3;7(290):290ps13. doi: 10.1126/scitranslmed.aab0194.
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising from local health care systems, cultural or political milieus, and unusual selected risk alleles or disease burdens. Such individual efforts might benefit from the sharing of approaches and lessons learned in other locales. The U.S. National Human Genome Research Institute and the National Academy of Medicine recently brought together 25 of these groups to compare projects, to examine the current state of implementation and desired near-term capabilities, and to identify opportunities for collaboration that promote the responsible practice of genomic medicine. Efforts to coalesce these groups around concrete but compelling signature projects should accelerate the responsible implementation of genomic medicine in efforts to improve clinical care worldwide.
在全球范围内，创新的基因组医学计划利用当地医疗保健系统、文化或政治环境以及独特的选定风险等位基因或疾病负担所产生的单一能力。这些单独的努力可能受益于分享其他地方的方法和经验教训。美国国家人类基因组研究所和美国国家医学院最近召集了这 25 个组织，对项目进行比较，研究当前的实施情况和期望的近期能力，并确定促进负责任的基因组医学实践的合作机会。将这些组织凝聚在具体但引人注目的标志性项目周围的努力，应该会加速负责任地实施基因组医学，以改善全球临床护理。
